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Acute regulation of Na/H exchanger NHE3 by adenosine A(1)
receptors is mediated by calcineurin homologous protein
Abstract
Adenosine is an autacoid that regulates renal Na(+) transport. Activation of adenosine A(1) receptor
(A(1)R) by N(6)-cyclopentidyladenosine (CPA) inhibits the Na(+)/H(+) exchanger 3 (NHE3) via
phospholipase C/Ca(2+)/protein kinase C (PKC) signaling pathway. Mutation of PKC phosphorylation
sites on NHE3 does not affected regulation of NHE3 by CPA, but amino acid residues 462 and 552 are
essential for A(1)R-dependent control of NHE3 activity. One binding partner of the NHE family is
calcineurin homologous protein (CHP). We tested the role of NHE3-CHP interaction in mediating
CPA-induced inhibition of NHE3 in opossum kidney (OK) and Xenopus laevis uroepithelial (A6) cells.
Both native and transfected NHE3 and CHP are present in the same immuno-complex by
co-immunoprecipitation. CPA (10(-6) M) increases CHP-NHE3 interaction by 30 - 60% (native and
transfected proteins). Direct CHP-NHE3 interaction is evident by yeast two-hybrid assay (bait, NHE3(C
terminus); prey, CHP); the minimal interacting region is localized to the juxtamembrane region of
NHE3(C terminus) (amino acids 462-552 of opossum NHE3). The yeast data were confirmed in OK
cells where truncated NHE3 (NHE3(delta552)) still shows CPA-stimulated CHP interaction.
Overexpression of the polypeptide from the CHP binding region (NHE3(462-552)) interferes with the
ability of CPA to inhibit NHE3 activity and to increase CHPNHE3(Full-length) interaction. Reduction
of native CHP expression by small interference RNA abolishes the ability of CPA to inhibit NHE3
activity. We conclude that CHPNHE3 interaction is regulated by A(1)R activation and this interaction is
a necessary and integral part of the signaling pathway between adenosine and NHE3.
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Summary 
Adenosine is an autocoid that regulates renal Na+ transport. Activation of 
adenosine A1 receptor (A1R) by CPA (N6-cyclopentidyladenosine) inhibits the Na+/H+ 
exchanger NHE3 via PLC/Ca2+/PKC signaling pathway. Mutation of PKC 
phosphorylation sites on NHE3 does not affected regulation of NHE3 by CPA but amino 
acid residues 462 and 552 are essential for A1R-dependent control of NHE3 activity. 
One binding partner of the NHE family is calcineurin homologous protein (CHP). We 
tested the role of NHE3-CHP interaction in mediating CPA-induced inhibition of NHE3 in 
opossum kidney (OK) and Xenopus laevis uroepithelial (A6) cells. Both native and 
transfected NHE3 and CHP are present in the same immunocomplex by co-
immunoprecipitation. CPA (10-6 M) increases CHP-NHE3 interaction by 30-60% (native 
and transfected proteins). Direct CHP-NHE3 interaction is evident by yeast-two-hybrid 
assay (bait; NHE3C-terminus; prey: CHP); the minimal interacting region is localized to the 
juxtamembrane region of NHE3C-terminus (aa 462-552 opossum NHE3). The yeast data 
was confirmed in OK cells where truncated NHE3 (NHE3∆552) still shows CPA-
stimulated CHP interaction. Overexpression of the polypeptide from the CHP-binding 
region (NHE3462-552) interferes with the ability of CPA to inhibit NHE3 activity and to 
increase CHP-NHE3Full length interaction. Reduction of native CHP expression by siRNA 
abolishes the ability of CPA to inhibit NHE3 activity. We conclude that CHP-NHE3 
interaction is regulated by A1R activation and this interaction is a necessary and integral 
part of the signaling pathway between adenosine and NHE3. 
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Introduction 
 
 Adenosine is an ubiquitous nucleoside generated from adenosine monophophate 
(AMP) by 5'-nucleotidase or from S-adenosyl-L-homocysteine (SAH) by SAH hydrolase 
(1,2). Renal adenosine is derived exogenously from the systemic circulation through 
mainly neuromuscular sources or endogenously via the intrarenal AMP and SAH 
pathways (2). Adenosine modulates many functions in mammals via binding to A1, A2A, 
A2B and/or A3 adenosine receptors (1,3). In the kidney, adenosine regulates glomerular 
filtration rate, renin release, erythropoietin production, cellular proliferation, and tubular 
water and Na+ transport (2,4). 
 
 Renal adenosine generation is markedly increased in response to hypoxia, 
ischemia or inflammation (2,3). It is well documented that adenosine can exert its 
protective effect against acute renal ischemia by containing inflammatory damage 
inflicted by circulating immune cells (2,3). A concomitant protective effect during 
ischemia can be achieved by reducing oxygen expenditure of the renal tubules through 
inhibition of Na+ transport, the principal oxygen consuming process (5,6). In the renal 
proximal tubules, which constitute over 70% of renal cortical mass, adenosine 
decreases the activity of the Na+/H+ exchanger NHE3 on the apical membrane of the 
proximal tubule (7-9). The inhibition of apical Na+ entry decreases the activity of the 
Na+-K+-ATPase and oxygen requirement of the highly aerobic proximal tubule (10,11). 
 
 NHE3 belongs to a superfamily of electroneutral mammalian Na+/H+ exchangers 
that has 8 members documented to date (12-17).  With the exception of NHE5, all NHE 
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isoforms are found in the kidney. All NHE’s have a predicted N-terminal hydrophobic 
ion-translocating domain and a variable C-terminal hydrophilic domain that harbors 
regulatory sequences (15-18). NHE3 is the isoform in the apical membrane based on 
antigenic (19,20) and functional data (21-24). Non-NHE3 mediated Na+/H+ exchange 
activity in the proximal tubule apical membrane (24) can theoretically be due to NHE8 
(14) but definitive data is still forthcoming. The current study focuses on NHE3. 
 
 Using a heterologous system, we found that acute A1R and A2R stimulation 
inhibits NHE3 via primarily PKC-coupled and PKA-coupled pathways respectively (7). In 
a recent report, we showed that early A2R activation is associated with a change in 
intrinsic transport activity of NHE3 while sustained inhibition of NHE3 was accompanied 
by a reduction of surface NHE3 protein (8). In addition, we showed that regulation of 
NHE3 activity by A2R activation is dependent on phosphorylation of NHE3 at two 
primary PKA target sites (8). Although there are some parallels between PKA and PKC 
dependent control of NHE3 activity, it is not known whether phosphorylation supports 
the A1R ability to regulate NHE3. 
 
 Recently, we presented evidence that inactivation of NHE3 activity in response to 
A1R stimulation depends on elevation of intracellular Ca2+ (9). Calcineurin homologous 
protein (CHP) is a recently described widely expressed Ca2+-binding EF-hand protein of 
approximately 22 kDa (25,26) with significant similarity to the regulatory B subunit of the 
heterodimeric protein phosphatase, calcineurin (26). CHP inhibits calcineurin phosphate 
activity (27) as well as interacts with NHE’s (26,28,29). CHP attenuates the stimulation 
of NHE1 by serum and a mutationally-activated GTPase in CCL39 cells (26). In PS120 
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fibroblasts, CHP binding to NHE1 does not affect surface NHE1 abundance but was 
necessary for surface NHE1 to function (28). The ability of CHP to alter NHE1 transport 
independent of surface NHE1 protein (28) renders it an attractive candidate for 
supporting adenosine-mediated change in intrinsic transport activity of NHE3. CHP 
associates with microtubules via a N-myristoylation-dependent mechanism that does 
not involve conventional microtubule-associated proteins (30) and is involved in 
vesicular transport (25). CHP also interacts with KIF1Bβ2, a molecular motor in neurons 
(31). These properties of CHP make it a plausible mediator in changes in trafficking 
between surface and intracellular NHE3 proteins. Although CHP clearly binds NHE3 
(28), the functional effect of CHP-NHE3 interaction has not been studied in the context 
of hormonal regulation of Na+ and H+ transport. In this manuscript, we described the 
role of CHP in mediating the regulation of NHE3 by adenosine.  
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 Experimental Procedures 
 
Cell culture and transfection. 
Experiments were performed on OK and A6/C1 cells. A subclone of OK cells 
selected on the basis of expression of PTH-sensitive Na+/phosphate co-transport (32) 
was cultured in a mixture of Dulbecco’s modified Eagle’s medium (DMEM and Ham’s 
F12) (Life Technologies Gibco, Karlsruhe, Germany and Carlsbad CA, U.S.A.) 
supplemented with 10% fetal calf serum (FCS), 2 mM glutamine and 50 I.U. ml-1 
penicillin and 50 µg ml-1 streptomycin in a humidified 95%/5% air/CO2 atmosphere at 
37°C and sub-cultured weekly. Cells generally reached confluence within 3-4 days and 
experiments were conducted 1-2 days after confluence. Studies on OK cells were 
performed between passages 23 and 57. A6/C1 cells are a subclone of A6-2F3 cells, 
functionally selected on the basis of high transepithelial resistance and responsiveness 
to aldosterone (33). These cells express endogenous basolateral Na+/H+ exchange 
activity (7,34) and transfected NHE3 is targeted to the apical membrane (7,8). A6/C1 
cell lines were grown in 0.8 x concentrated DMEM, supplemented with 25 mM NaHCO3, 
10% heat inactivated fetal bovine serum, 50 I.U. ml-1 penicillin and 50 µg ml-1 
streptomycin in a humidified 95%/5% air/CO2 atmosphere at 28°C. For A6 cells 
transfected with NHE3, medium was supplemented with 450 µg ml-1 hygromycin-B. 
Cells were subcultured weekly by trypsinization [Ca2+-Mg2+-free salt solution containing 
0.25% (w/v) trypsin and 2 mM EGTA]. Cells generally reached confluence between 7 to 
8 days after seeding and studies were performed between passages 6 and 43.  
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For transient transfection, cells were grown to approximately 70% confluence in 
culture dishes and 1.3 µg of cDNA was introduced into cells using Lipofectamine 
(Gibco, Carlsbad, CA, USA). Transfection efficiency was monitored by co-transfection of 
the pEGFP plasmid (Clontech, Palo Alto, California, USA) and was approximately of 
70%. For stable transfection, A6 cells were grown to 20-25% confluence in 35 mm 
tissue culture dishes and cDNA was introduced into cells using FugeneTM 6 (Boehringer, 
Mannheim, Germany). The construct of interest (1.5 µg) was co-transfected with the 
p3’SS∆LacI vector (0.5 µg) to allow selection by hygromycin B resistance (7). Clonal 
populations of transfected cell lines obtained by ring cloning were maintained in 
hygromycin. Hygromycin-resistant clones were further selected for NHE3 transcripts by 
RT-PCR (data not shown) as previously described (8). Cells used for experiments were 
treated for 6 to 7 days with 1 µM dexamethasone known to accelerate maturation and 
differentiation (35). To ensure true segregation of the apical and basolateral surface, we 
established that A6/C1 cell lines exhibited reproducible high transepithelial resistances. 
Untransfected A6/C1 cells transepithelial resistance (TER) was comparable with NHE3-
transfected ones (data not shown).  
 
Plasmid constructs 
Generation of constructs encoding for wild type and mutated forms of rat-NHE3 
(at either a single endogenous serine position or at six endogenous serine positions on 
the cytoplasmic tail of NHE3) has been previously described (8,36,37). Full length and 
truncated forms of NHE3 cDNAs were generated by high fidelity PCR using forward and 
reverse primers flanked with the appropriate restriction endonuclease sites and sub-
cloned into the desired plasmids. All constructs were verified by direct sequencing. 
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Mammalian expression plasmids and inserts included: 1. C-terminal c-myc and 
hexahistidine (6His) tagged rat and opossum NHE3 (NHE3/myc/6H) (pcDNA3.1, 
Invitrogen, Carlsbad, CA). 2. C-terminal human influenza hemagglutinin (HA)-tagged 
mouse-CHP (CHP/HA) (pMHTM, Roche, Indianapolis, IN). 3. C-terminal enhanced green 
fluorescent protein (eGFP)-tagged OK-NHE3 (NHE3/eGFP) (Clontech, Palo Alto, CA). 
4. N-terminal Flag-tagged OK-NHE3 sequence comprising aa 462-552 (Flag/NHE3462-
552) (pFLAg-CMVTM-2; Sigma, St. Louis, Missouri). For yeast-two-hybrid bait 
construction, the C-terminus of mouse NHE3 was cloned from mouse kidney poly-A+ 
RNA using primers derived from rat NHE3 (forward 5’-
gccgaattctttcagggcctgaccattaagcc-3’; reverse 5’-cggttgacatcacatgtgtgtggactcagg-3’) 
using low stringency PCR. After sequence verification, EcoRI and SalI restriction sites 
were introduced by PCR into cDNA fragments polymerized from wild type mouse NHE3 
(mNHE3C-terminus) as template. The following bait constructs [NHE3382-839 (aa 382-839), 
NHE3382-794 (aa 382-794), NHE3382-557 (aa 382-557), NHE3382-501 (aa 382-501), NHE3766-
839 (aa 766-839), NHE3794-839 (aa 794-839)] made as in-frame fusion proteins with the 
LexA DNA binding domain (DNA-BD) in the vector pBTM116 carrying the TRP1 
selection marker (38) (Clontech, Palo Alto, CA).  
 
Measurement of Na+/H+ exchange activity. 
NHE activity was measured as the rate of Na+-dependent recovery of cytosolic 
pH (pHi) following an acid load (NH4Cl prepulse) as described previously (8). Confluent 
cells on permeable support (collagen-coated coverslip with a 1.5 mm central perforation 
covered by a Millicell-CM 0.4 µm Teflon filter (Millipore, Eschborn, Germany) were dye-
loaded (4.2 µM BCECF-AM; 50 µM probenecid) in Na+-containing medium (60 min.) 
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and superfused continuously with Na+-medium on the stage of an inverted microscope 
(Zeiss Axiovert 100). After recording baseline pHi, cells were acid-loaded (Na+-medium 
+ 40 mM NH4Cl, followed by Na+-free medium) and subsequent addition of Na+-medium 
yielded NHE activity as the rate of pHi recovery. In A6 transfectants, addition of Na+-
medium to either the apical or basolateral cell surface allowed independent polarized 
measurement of NHE activity. Media used in pH measurements were nominally 
bicarbonate-free. For OK cells: isotonic Na+-medium contained (in mM): 130 NaCl, 4 
KCl, 1 CaCl2, 1 MgSO4, 1 NaH2PO4, 18 glucose and 20 HEPES buffered to pH 7.4 with 
NaOH; Isotonic TMA+-medium composed of (in mM): 130 tetramethyl-ammonium 
chloride (TMACl), 4 KCl, 1 CaCl2, 1 MgSO4, 1 TMAH2PO4, 18 glucose and 20 HEPES 
pH 7.4 with TMAOH. For A6 cells: isotonic Na+-medium contained (in mM): 110 NaCl, 3 
KCl, 1 CaCl2, 0.5 MgSO4, 1 KH2PO4, 5 glucose and 10 HEPES pH 7.5 with Tris. 
Isotonic TMA+-medium contained (in mM): 110 TMACl, 3 KCl, 1 CaCl2, 0.5 MgSO4, 1 
KH2PO4, 5 glucose and 10 HEPES pH 7.5 with Tris. The microfluorimetry was 
performed on a Zeiss Axiovert 100 inverted microscope with a Zeiss LD “Achroplan” 
63x/0,75 objective, coupled to a multiwavelength illumination system (Polychrome II 
from T.I.L.L. Photonics GmbH, Gräfelfing, Germany). A monochromatising device with 
an integral light source (75 Watt Xenon arc lamp) alternatively selected the excitation 
wavelengths (495 ± 10 and 440 ± 10 nm) via a galvanometric scanner and directed to 
the cells via a 515 nm dichroic mirror and a 535 ± 25 nm band-pass collected filter 
fluorescence emission. Photometric data were acquired using the MetaFlour software 
(Visitron Systems, Puchheim, Germany). Calibration of the fluorescence signals to pHi 
cells was performed in the presence of the K+/H+ ionophore nigericin (0.5 µM) in isotonic 
K+-rich-medium as described previously (39). For A6 cells the isotonic K+-rich-medium 
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used contained (in mM): 105 KCl, 8 NaCl, 1 CaCl2, 0.5 MgSO4, 1 KH2PO4, 5 glucose 
and 10 HEPES buffered to various pH values for calibration of intracellular BCECF. 
 
Quantification of surface NHE3 antigen. 
The assay was performed as described previously (40). OK cells were grown to 
confluence on 100 mm culture dishes while A6 cells stably expressing wild-type OK-
NHE3 were grown on 40 cm2 collagen coated Nucleopore Polycarbonate Track-Etch 
membranes (Fischer Scientific, Hampton NH, USA). The latter configuration allowed 
polarized quantification of NHE3 expression in the apical vs. basolateral membranes. 
After exposure to agonists or vehicle, cells were rinsed in Ca/Mg/PBS [in mM: 150 
NaCl, 10 Na2HPO4, pH 7.4, 0.1 CaCl2, 1 MgCl2], incubated with the arginine and lysine-
reactive NHS-SS-biotin [2 mg ml-1] (Pierce, Rockford, IL, USA) in buffer [in mM: 150 
NaCl, 10 triethanolamine, pH 7.4, 2 CaCl2] for 1 h. After quenching in Ca/Mg/PBS 
supplemented with 100 mM glycine, cells were lysed in biotin-RIPA buffer [in mM: 150 
NaCl, 50 Tris-HCl, pH 7.4, 5 mM EDTA, 1% (v/v) Triton X-100, 0.5% (w/v) 
deoxycholate, 0.1% (w/v) SDS], centrifuged (109,000 x g at rmax, 50,000 rpm, 25 min., 4 
°C, Beckman TLX ultracentrifuge, TLA 100.3 rotor, Beckman, Fullerton, CA), and 
protein content in the supernatant was quantified by the Bradford method (Bio-Rad, 
Hercules, CA, USA). Equal protein amounts of cell lysate were equilibrated with 
streptavidin-agarose beads at 4°C, washed sequentially with solution A [in mM: 50 Tris-
HCl, pH 7.4, 100 NaCl, 5 EDTA], solution B [in mM: 50 Tris-HCl, pH 7.4, 500 NaCl], and 
solution C [in mM: 50 mM Tris-HCl, pH 7.4]. Biotinylated proteins were released by 
incubation in 100 mM dithiothreitol, reconstituted in Laemmli’s buffer and subjected to 
SDS-Page and blotted with anti-OK-NHE3 antisera (#5683) (40). The integrity of the 
 10
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung, on February 8, 2010
w
w
w
.jbc.org
D
ow
nloaded from
 
monolayer was confirmed by measurement of trans-epithelial resistance prior to the 
experiment, and again following surface labeling with NHS-SS-biotin. 
 
Yeast-two-hybrid. 
Bait vectors were transformed into Saccharomyces cerevisiae (strain L40) 
containing the genotype MATa trp1 leu2 his3 LYS2::lexA-HIS3 URA3::LexA-LacZ 
(38,41). Yeast cells were grown in YPDA medium (1% yeast extract, 2% Difcopeptone, 
2% glucose, 0.003% adenine hemisulfate) or the synthetic minimal Trp dropout medium 
(SD-Trp) complemented with 0.003% adenine hemisulfate (42). For transformation, a 
YPDA culture from L40 (20 ml) grown to an A600 of ~1 (18 h) was centrifuged at 1,200 g 
for 3 min., washed with 40 ml of distilled H2O, and resuspended in 1 ml of distilled H2O. 
Aliquots of 50 µl of competent yeast were treated with 240 µl of polyethylene glycol 
(50% w/v), 36 µl of 1 M LiAc, 25 µl of single-stranded DNA (2.0 mg/ml), 50 µl of distilled 
H2O and 1 µg of the plasmid of interest, according to Gietz and Schiestl (43). After an 
incubation at 30°C (30 min. at 260 rpm) followed by a heat shock at 42 °C (20 min.), 
cells were harvested at 16500 rpm for 15 sec in a table top centrifuge, resuspended in 
100 µl of distilled H2O and plated onto 14-cm SD-Trp Petri dishes. 
 
A cDNA library (MATCHMAKER, Clontech, Palo Alto, CA) of whole adult mouse 
kidneys was screened as previously described (44) except mNHE3cyto was used as bait. 
cDNA inserts were ligated to the C-terminus of the GAL4 activation domain in vector 
pACT2, which delivers the LEU2 nutritional gene for complementation. Putative positive 
colonies were isolated by consecutive colony-lift assays where the permeabilized cells 
transferred onto Whatman filters were overlaid with 0.2 mg/ml 5-bromo-4-chloro-3-
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indolyl β-D-galactopyranoside (Alexis, Lausen, Switzerland), 150 mM NaCl, 50 mM Tris-
HCl (pH 7.4), and 0.8% agarose (45,46). Yeast DNA of true positives was isolated (47) 
and prey plasmids were rescued by transformation into KC8 cells, which carries trpC, 
leuB, and hisB mutations (48). Positivity of purified preys was validated once again in 
yeast. Insert sizes were checked by BglII digestion. After direct sequencing, identical 
sequences were grouped via ClustalW at Pôle Bio-Informatique (Lyonnais) or via Pileup 
from Genetics Computer Group (Oxford) and overlaps connected by the Contig 
assembly program (Baylor College of Medicine, Houston TX). Searches for protein 
relationships were performed using BLAST (NCBI, Bethesda, MD) (49). A number of 
positive preys were identified as either partial or full length CHP. Truncated NHE3 baits 
were constructed as described above and tested against CHP. Briefly, over night 
cultures of yeast previously transformed with selected bait vectors were washed and 
transformed using a reaction mixture of small-scale yeast transformation containing 10 
µg cDNA from each prey as described. After 5 days on SD-Trp/Leu/His plates, 
prototrophies were tested for LacZ expression by a colony-lift assay. (45,46).  
 
Immunoprecipitation and immunoblot.  
Untransfected and transient transfected OK cells, treated with either vehicle or 
CPA, were lysed in buffer [in mM: 150 NaCl, 50 Tris-HCl pH 8, 5 EDTA, 1 EGTA 1% 
(v/v) TritonX-100, and mixtures of protease inhibitors (in mg/ml) 100 PMSF, 4 leupeptin, 
4 aprotinin, 10 pepstatin] and incubated at 4°C for 1 hr. Lysate was centrifuged (14,000 
x g, 4°C, 30min.) and supernatants was retrieved and protein content was quantified by 
the Bradford method (Bio-Rad). For immunoprecipitation, supernatants were then 
incubated with rabbit anti-NHE3 polyclonal antibodies (#5683, 1:200 dilution) or anti-
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CHP polyclonal antibodies (1:200 dilution, kindly provided by Dr. Dianne L. Barber, 
University of California San Francisco) for 2 hr at 4 °C. Other antisera used included 
rabbit anti-HA polyclonal (1:200 dilution; Sigma, St. Louis, MO, USA), rabbit anti-6His 
(1:200 dilution; Invitrogen, Carlsbad, CA, USA), mouse anti-c-myc (1:200 dilution; 
Sigma, St. Louis, MO, USA) or mouse anti-FLAG monoclonal (1:200 dilution; Sigma, St. 
Louis, MO, USA) antibodies. After that, 30 µl protein-G agarose beads (1:1 suspension; 
Calbiochem, San Diego, California, USA) were added and samples were incubated 
overnight at 4 °C. Immunoprecipitates were washed 4 times with 1 ml of lysis buffer and 
resuspended in 40 µl in 1 x SDS loading buffer (containing in mM: 5 mM Tis-HCl, pH 
6.8, 1% SDS, 10% glycol, 1% β-mercaptoethanol, and 0.004% bomophenolblue), 
heated (85 oC, 10 minutes), size fractionated by SDS-PAGE, and electrophoretically 
transferred to PVDF membranes (Millipore ImmobilinTM-P transfer membranes; 
Millipore, Bedford, MA). After blocking (5% nonfat milk, 0.05% Tween-20 in PBS, 1 h), 
blots were probed with polyclonal or monoclonal antibodies as indicated in the legends 
(1:1,000 4 oC, overnight). After washing (0.1% Tween-20 in PBS x 3), the second 
antibody, anti-rabbit or anti-mouse IgG coupled to horseradish peroxidase, was applied 
(1:10,000, 1 h). After three more washes in 0.1% Tween-20 in PBS, immunoreactive 
bands were visualized using enhanced chemiluminescence.  
For total protein extract, cells were disrupted by sonication and harvested at 
16500 rpm for 10 min in a tabletop centrifuge. 60 µg of total lysate, fractionated by SDS-
PAGE, was immunoblotted by anti-CHP antibody, anti-NHE3 antibody (#5683) or anti-
Na/KATPasi antibody (α2F) (Developmental Studies Hybridoma Bank, University of 
Iowa, Iowa City, IA). 
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Confocal fluorescent imaging.  
OK cells were plated on glass coverslip and A6 cells were plated onto permeant 
filter supports (4.7 cm2, Transwell; Costar, Cambridge, MA) previously coated with a thin 
layer of rat collagen. Transiently transfected cells (48 h later) were fixed (4% formalin in 
PBS for 10 min.), permeabilized (0.1 % Triton-X 100 in PBS for 10 min.), blocked by 5% 
BSA in PBS at 37 °C for 30 min. Specimens were incubated with rabbit anti-HA 
polyclonal antibodies (1:200 dilution, Sigma, St. Louis, Missouri, USA) and mouse anti-
FLAG monoclonal antibodies (1:100 dilution; Sigma, St. Louis, Missouri, USA) at 37 oC 
for 1 h, followed by Rhodamine Red-X conjugated anti-rabbit and Cy5-conjugated anti-
mouse (all secondary polyclonal antibodies from donkey, Jackson ImmunoResearch 
Laboratories), respectively. Confocal fluorescent images were visualized through a 
Zeiss 100 X objective lens using Zeiss LSM-410 laser-scanning confocal microscope. 
Fluorescence of Rhodamine Red, GFP, and Cy5 were detected using excitation laser 
(wavelength in nm) of 568, 488, and 633 and emission filter of 590 long-pass filter, 510-
560 band-pass filter, and 670-810 band-pass filter, respectively. In Figure 10B, image of 
Flag- tagged NHE3462-552 was assigned of pseudo-color either blue or green. 
 
For imaging of NHE3 in live cells, OK and A6 cells on glass cover slips were 
transfected with NHE3/eGFP and maintained for 48 h. Cover slips were placed on the 
stage of an inverted confocal fluorescence microscope and living green fluorescent cells 
were selected before the treatment. CPA or vehicle was then added to the cell medium. 
After the stated period of incubation images were acquired and the pattern of 
expression of transporters was compared with that before treatment.  
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Selection and preparation of siRNA duplexes from the target CHP sequence.  
Target region was selected from cDNA sequence of endogenous opossum CHP. 
By homology cloning we identified 300 nucleotides downstream of the CHP start codon 
(GenBank accession number: AY281349). The AA-N19 mRNA target was synthesized 
by Dharmacon Research Company (Lafayette, CO, USA), sequences were: 5’-
agagcaaagaugugaaugg-3’ (sense strand) and 5-ccauucacaucuuugcucu-3’ (antisense 
strand). GL2 (firefly luciferase gene) siRNA was synthesized according to Elbashir et al. 
(50). The 21 nucleotide siRNA duplex targeting OK mRNA sequence of the protein 
tyrosine kinase, Pyk2 (5’-aaugcccuugauaagaagucc-3’) was kindly provided by Dr. 
Patricia Preisig (Univ Texas Southwestern Med Ctr, Dallas). Oligos were provided at the 
concentration of 20 µM, purified, annealed duplex, ready to use for transfection. 
Approximately 24 hours prior transfection OK cells were plated at an appropriate cell 
density so that they were ∼70% confluent the following day. For the complex formation 
were used 7 µl of the TransIT-TKO Transfection Reagent (Mirus Corporation, Madison, 
WI, USA) into 100 µl of serum-free medium. Diluted TransIT-TKO Reagent was 
incubated at room temperature for 20 min. siRNA (70 nM) was added to the complex 
and incubated at room temperature for additional 20 minutes. TransIT-TKO 
Reagent/siRNA complex mixture was given to OK cells and were incubated with the 
transfection reagents for 48 hours. Assays for silencing were performed after 48 hours 
of serum deprivation. 
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Statistical Analyses. 
 Results are represented as mean ± standard error (S.E.M.). Quantitative 
differences between control and test conditions were assessed statistically by analysis 
of variance. Probability (p) < 0.05 was considered statistically significant. 
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Results 
 
Activation of A1R inhibits NHE3 activity.  
We previously showed that acute activation of A1R decreases NHE3 activity in 
renal epithelial cells (7,9). This study uses OK cells expressing endogenous NHE3 and 
A6 cells expressing transfected NHE3 to analyse the mechanism underlying A1R–
induced inactivation of NHE3. As shown in Fig. 1A, activation of A1R in OK cells with  
10-6 M CPA (N6-cyclopentyladenosine) reduced the activity of the native apical NHE3 by 
31 % and 35 % at 15 and 30 minutes respectively. As shown in Fig. 1B and 1C, CPA 
had similar effects on opossum or rat NHE3 stably transfected into A6 cells. A1R 
activation in the apical membrane by 10-6 M CPA for 15 or 30 minutes decreased the 
activity of transfected OK-NHE3 by 27 % and 40 %, respectively (Fig 1B), and reduced 
the activity of transfected rat-NHE3 by 31 % and 39 %, respectively (Fig 1C). In both 
transfected and untransfected A6 cells, exposure to CPA (10-6 M for 15 min.) inhibited 
the native basolateral Xenopus NHE (XNHE) activity (Fig. 1D). 
 
CPA decreases surface NHE3 protein.  
One mechanism that has been shown to acutely alter NHE3 activity is the 
change in cell surface NHE3 protein abundance (8,40,51-54). We used surface 
biotinylation to determine whether the decrease in NHE3 activity in response to 
activated A1R is associated with reduction in surface NHE3 antigen. As shown in Figure 
2, there was no detectable change in surface or total native OK-NHE3 antigen after 15 
minutes of 10-6 M CPA. However, 30 minutes of 10-6 M CPA induced a 35% reduction in 
surface NHE3. Similar results were obtained from studying A6 cells expressing 
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transfected OK-NHE3 protein (Fig. 3A and Fig. 3B). In both cell lines, CPA did not affect 
the amount of total cellular NHE3 protein (see Fig. 2A and Fig. 3A). In addition to 
biochemical biotin accessibility assays, we also studied CPA-induced changes of NHE3 
distribution in live cells transiently expressing OK-NHE3 tagged with enhanced green 
fluorescent protein (OK-NHE3/eGFP). Fluorescent microscopy showed that CPA 
caused a visible decrease in surface NHE3 at 30 minutes of exposure to 10-6 M CPA 
(Figure 2C). Comparable findings were obtained in A6 cells transiently expressing OK-
NHE3/eGFP (Figure 3C). Exposure to vehicle did not cause any change in NHE3/eGFP 
distribution in either cell lines (not shown). 
 
Identification of structural elements required for downregulation of NHE3 by CPA. 
According to the preceding results, inhibition of NHE3 activity by CPA at 15 
minutes is exclusively due to a reduction of intrinsic NHE3 activity. We recently have 
shown that A1R-mediated inactivation of NHE3 is dependent on protein kinase C (PKC) 
(7,9). Phosphorylation of NHE3 is an early event in regulation of NHE3 by protein 
kinases (36,37,55,56). Elimination of phosphoserines on NHE3 may disrupt CPA 
regulation of NHE3 activity. To test this hypothesis, we assayed A6 cells stably 
expressing rat-NHE3 bearing either single or multiple serine substitutions for their 
response to CPA. As shown in Figure 4A, substitution of serine residues at a single 
position (S605G) or multiple positions (S513G, S552A, S575A, S634A, S661A, S690G) 
on NHE3 did not appreciably affect NHE3 inactivation by 10-6 M CPA. Similar results 
were obtained in studies using the PKC agonist PMA (phorbol 12-myristate 13-acetate). 
This is in contradistinction to the previous data in fibroblasts where phosphoserines 
were necessary but not sufficient for alteration of NHE3 activity by PMA (37). Co-
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exposure to the PKC antagonist calphostin C (10-8 M for 15 min.) completely reversed 
NHE3 inhibition induced by either CPA or PMA (data not shown). CPA or PMA reduced 
the activity of basolateral XNHE in transfected cell lines to an extent that is similar to the 
effect of either of the agonist on XNHE in untransfected A6 cells (Figure 4B). These 
findings suggest that direct phosphorylation of NHE3 is not necessary for A1R-induced 
down-regulation of NHE3. 
 
In the following series of experiments we tested the functional behavior of 
truncated versions of OK-NHE3 to identify the region in the NHE3 C-terminus that is 
essential for the A1R response. Figure 5A gives an overview on the truncated NHE3’s 
screened for the ability of A1R activation to regulate NHE3. Compared to wild-type 
NHE3, mutants lacking the carboxyl tail distal to position 462 (NHE3∆462) were 
completely unresponsive to 15 minutes treatment with 10-6 M CPA, whereas NHE3 
truncated at position 552 (NHE3∆552) retained full response to CPA (Figure 5B). 
Similarly, NHE3∆462 lost PMA responsiveness, whereas NHE3∆552 and NHE3∆640 were 
inhibited by 10-7 M PMA (Figure 5B). Co-exposure to calphostin C (10-8 M for 15 min.) 
prevented the response of OK-NHE3∆552 to either CPA or PMA (data not shown). The 
endogenous XNHE responded to either CPA or PMA in A6 cell lines expressing wild-
type or truncated versions of OK-NHE3 (Figure 5C). Various truncations of NHE3 per se 
did not significantly affect whole cell NHE3 protein expression (data not shown). We 
conclude that A1R-induced inhibition of NHE3 requires regulatory elements within 
residues 462 - 552 of the carboxyl-terminal domain of NHE3. 
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Identification of CHP (calcineurin B homologous protein) as a CPA-regulated 
NHE3 binding protein.  
By analogy to the molecular mechanism allowing inactivation of NHE3 by PKA, 
elevated Ca2+ or PKC (53,57-60), we hypothesized that PKC-mediated inactivation of 
NHE3 by activated A1R involves interaction of NHE3 with a regulatory protein. In a 
yeast-two-hybrid screen of an adult mouse kidney cDNA library using full-length murine-
NHE3 C-terminus as bait, full length murine CHP (calcineurin B homologous protein) 
repeatedly came out as positive interacting clones. CHP has previously been reported 
to bind to NHE3 near the vicinity of the region of aa 462-552 essential for A1R-induced 
regulation (28). We next examined whether CHP interacts with the subdomain of NHE3 
that is critical for A1R dependent control of NHE3 activity. To this end, we used 
truncated versions of the C-terminal domain of murine NHE3 as bait in the yeast-two-
hybrid assay. As shown in Fig. 6, CHP specifically interacted with murine NHE3 aa 381 
to 557 which is homologous to the CPA-sensitive domain on OK-NHE3 (aa 462-552). 
CHP interacted with a minimal version of the juxtamembrane C-terminal cytoplasmic 
domain of NHE3 comprising aa (murine) 338 to 501 (Fig. 6). In contrast, baits devoid of 
this region of the NHE3 C-terminus showed no interaction with CHP (Fig. 6). 
 
To test for association of CHP with full-length NHE3 in vertebrate cells and to 
determine whether CPA modulates the association, we performed co-
immunoprecipitation studies. Immunoprecipitation of native NHE3 (Fig. 7A) brought 
down native CHP in the immune complex (Fig. 7A). Importantly, exposure to CPA 
increased the amount of NHE3 bound to native CHP by approximately 30% (Fig. 7A 
and D). Additional evidence for an association of CHP and NHE3 was obtained in 
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studies using OK transiently expressing 6His-tagged rat-NHE3 and HA-tagged murine-
CHP. As shown in Figure 7B, anti-HA antibody co-precipitated 6His-tagged rat-NHE3 
only in double-transfected OK cells but not in OK cells that were not transfected (Fig. 
7B) or solely transfected with 6His-tagged rat-NHE3 (data not shown). Again, exposure 
of double-transfected OK cells to CPA increased the amount of NHE3 bound to CHP by 
60% (Fig. 7B and D). 
 
If the critical interacting region on NHE3 is indeed aa 462-552, the association 
between CHP and NHE3 should be preserved with truncation of OK-NHE3 at aa 552 
and disrupted by truncation of OK-NHE3 at aa 462. Co-transfection of myc-tagged OK-
NHE3∆552 and HA-tagged CHP in OK cells showed intact co-immunopreciptation as well 
as increased NHE3-CHP association in response of CPA (Figure 7C). Whereas co-
expression of myc-tagged OK-NHE3∆462 and HA-tagged CHP in OK cells demonstrated 
no association of NHE3 with CHP (Figure 7D). Figure 7E summarized the CPA-
mediated increases of association of CHP with NHE3 (native and transfected proteins). 
 
Subcellular localization of CHP and NHE3 in OK cells and A6 cells.  
In the next series of experiments we compared subcellular localization of NHE3 
and CHP in OK cells and A6 cells transiently expressing HA-tagged CHP (HA/CHP) and 
NHE3/eGFP by confocal fluorescent microscopy. HA-tagged CHP showed primarily 
intracellular distribution (Fig. 8A, upper two panels xz section) whereas NHE3/eGFP 
localizes to both intracellular compartment as well as the apical membrane (Figure 8A 
bottom two panels xz section). However, there is definite co-localization of HA/CHP and 
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NHE3/eGFP in the apical membrane in both OK and A6 cells (Figures 8B and C, yellow 
signal of the merged composite).  
 
Functional importance of CHP-NHE3 interaction for CPA-dependent control of 
NHE3 activity.  
We used two approaches to define the functional significance of the CHP-NHE3 
interaction in A1R-dependent control of NHE3 activity. First we attempted to create a 
“dominant negative” NHE3 polypeptide. We transiently transfected a construct 
expressing aa 462 to 552 of OK-NHE3 (NHE3462-552) in OK cells to attempt to 
stoichiometrically bind endogenous CHP and competitively inhibit the endogenous 
CHP-NHE3 interaction. To validate this approach, we first established that transfected 
NHE3462-552 actually competes with wild-type full length NHE3 for CHP binding. To this 
end, OK cells were triple-transfected with HA-tagged CHP (HA/CHP), 6His-tagged 
NHE3 (NHE3/6H) and Flag-tagged NHE3462-552 (Flag-NHE3462-552). Lysate from vehicle 
or CPA-treated cells were subjected to immunoprecipitation by anti-6His or anti-Flag 
antibodies and immunoblotted with anti-HA antibody. As illustrated in Fig. 9, both 
NHE3462-552 and full length NHE3 interacts with CHP. Interestingly, in the presence of 
NHE3462-552, CPA failed to increase binding of full length NHE3 to CHP (Fig. 9). To 
further substantiate that NHE3 and NHE3462-552 compete for CHP-binding, we examined 
OK cells transiently expressing HA/CHP, NHE3/eGFP and Flag/NHE3462-552 by 
immunocytochemistry. Figure 10A highlights expression of the 3 heterologous 
recombinant proteins in OK cells. Flag/NHE3462-552 is diffusely distributed in OK cells as 
compared to NHE3/eGFP which has a visibly apical distribution. Fig. 10B highlights the 
co-localization of either NHE3 or NHE3462-552 with CHP (yellow signal of the merged 
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composite). Localization of CHP and NHE3 was comparable to results shown in Fig. 8 
where apical targeting of both proteins is evident (Fig. 10B left panel). These findings 
support the notion that expression of NHE3462-552 competes for binding of NHE3 to CHP. 
Finally, we measured NHE3 activity in OK cells transiently expressing the NHE3462-552 
peptide. As shown in Fig. 11, expression of NHE3462-552 does not influence baseline 
NHE3 activity but abolished the CPA-induced inhibition of NHE3 activity. 
 
The second approach we used to demonstrate the functional significance of CHP 
for A1R-induced regulation of NHE3 was to reduce the expression level of endogenous 
CHP. To this end we cloned a partial sequence of OK CHP to enable construction of 
AA(N19)TT duplex RNA sequence (siRNA) which upon transfection in OK cells acts to 
silence expression of OK-CHP. The opossum CHP is aligned against the murine, rat 
and human homologue in Fig 12A. siRNA sequence was selected from a region of the 
CHP third EF-hand motive. Figure 12B and C show (by immunoblot and 
immunostaining respectively) that CHP siRNA-transfected OK cells exhibited markedly 
reduced expression of endogenous CHP (by approximately 70%, see Fig. 12B). In 
contrast when siRNA targeting coding sequence for Pyk2 and GL2 were used, no 
changes in CHP protein expression were detected (Figure 12B). Transfection of OK 
cells with siRNA targeting CHP reduced total NHE3 expression by 50% but did not 
modify Na/K ATPase protein abundance (Fig. 12D). Interestingly, when CHP expression 
is reduced, baseline NHE3 activity is significantly decreased and CPA no longer 
regulates NHE3 function (Fig. 12E). Together, these findings strongly suggest that CHP 
is an essential co-factor required for inhibition of NHE3 by activated A1R. Furthermore, 
CHP may trigger other mechanisms involved in NHE3 regulation. 
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Discussion 
 
In addition to maintenance of sodium homeostasis under physiological 
conditions, a rise in adenosine after renal ischemia has protective effects against renal 
cell damage via a multitude of intrarenal and extrarenal mechanisms (2,61-63). 
Regulation of NHE3 activity by adenosine may represents a versatile mechanism to 
adapt the energy supply/demand balance of the proximal tubule under physiological as 
well as certain pathophysiological conditions. Our recent findings support a role of A1R 
activation in modulation of proximal tubule Na+ transport via regulation of NHE3 (7,9). 
Using homologous as well as heterologous systems, we found that acute A1R 
stimulation inhibits NHE3 primarily via a Ca2+ sensitive, PKC-coupled pathway (7,9). In 
the present study we report that stimulation of A1R affect NHE3 in a mode similar to that 
of parathyroid hormone, dopamine or A2R activation (8,40,51,52). Early effects (<30 
min.) of A1R regulate intrinsic transport activity of NHE3, and more sustained (>30 min.) 
inhibition is associated with reduction of NHE3 protein in the plasma membrane. 
Reduction of NHE3 cell surface expression (within 30 min.) was not accompanied by a 
comparable decreased of NHE3 activity at 30 min. The present findings are quite similar 
to that seen in response to PTH or dopamine in OK cells (40,52). The molecular 
mechanisms underlining this observation are currently unknown. Two hypothetical 
models have been proposed, which may explain the findings (52). In the first model, at 
15 minutes only a fraction of surface NHE3 is down regulated. This same fraction at 30 
minutes undergoes endocytosis leaving the remaining surface transporters running at a 
rate similar to control conditions. In the second model, all surface NHE3 is inhibited 
(within 15 min.) but only a restricted population of NHE3 becomes internalized at 30 
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min. Those transporters that are not targeted to be internalized recover their transport 
activity with time (30 min.). Currently, there is no data to discern these two paradigms. 
 
In fibroblasts, phosphorylation of NHE3 may have a permissive role in regulation 
of NHE3 activity by PKC (37) but NHE3 phosphorylation is insufficient to mediate the 
functional regulation (37,64). In A6 cells, rat NHE3 bearing either single or six 
substitutions of PKC phosphorylation sites retained functional regulation of transport 
activity by A1R activation. However, our present findings do not exclude the possibility 
that other phosphorylated sites on NHE3 C-terminus are involved in A1R induced 
inactivation of NHE3. 
 
A1R-induced NHE3 inhibition requires the integrity of a domain located between 
amino acid (aa) 462 and 552 of the opossum NHE3 sequence. This domain does not 
include classical PKC consensus sites compatible with the notion that activation of A1R 
does not involve changes in NHE3 phosphorylation. A cofactor recently identified to 
bind in the vicinity of this region is CHP (28). By screening for proteins that may function 
as regulators of NHE3 in a yeast-two-hybrid study, we provided evidence that CHP 
interacts directly with a region of NHE3 corresponding to the domain that mediates A1R-
induced inhibition. The juxtamembrane localization of the binding domain of CHP on 
NHE3 is consistent with a previous report (28). This prompted us to study the role of 
CHP in NHE3 regulation by adenosine. 
 
Association of CHP with NHE3 in vivo was confirmed by co-immunoprecipitation 
in OK cells with either native or transfected NHE3 and CHP. OK cells have been shown 
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recently to predominantly express the endogenous CHP2 isoform (65). However, our 
findings demonstrate that the OK cell CHP exhibits highest homology with human and 
murine CHP1 but not CHP2. There is considerable heterogeneity amongst different OK 
cells and our cell line may express both CHP1 and CHP2 but the RT-PCR with CHP1-
derived primers selectively picked out OK CHP1 rather than CHP2. Similar to reported 
data on direct interaction of cloned CHP from different species with NHE3 (28,65), our 
results in OK cells indicate interaction of CHP with NHE3 under basal conditions. In 
addition, we showed that NHE3-CHP binding increases upon A1R stimulation with CPA 
and we further provided functional data to support the role of this interaction in 
regulation of NHE3 by either CPA.  
 
The CHP-interacting region on NHE3 derived from the yeast-two-hybrid data was 
confirmed in OK cells by the observation that truncation of NHE3 at aa 552 still retained 
baseline and CPA-activated association of CHP with NHE3. In contrast, truncation of 
NHE3 at aa 462 showed no binding of NHE3 to CHP. The functional significance of this 
interaction was supported by additional findings. Truncation of NHE3 beyond aa 552 
abolished CPA-induced regulation. This finding per se does not rule out regulatory 
functions other than CHP-binding in this region. However, transient overexpression of a 
NHE3 peptide aa 462 to 552 that competes for binding of CHP to NHE3, prevented 
CPA-induced early inhibition of NHE3 activity and CPA-mediated binding of CHP to 
NHE3. The functional role of CHP was further secured by the fact that reduction of 
native CHP by siRNA abolished the ability of CPA to inhibit NHE3 activity. Importantly 
reduction of native CHP by siRNA influence baseline NHE3 activity and total NHE3 
protein abundance suggesting that CHP may influence NHE3 regulation by activating 
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diverse mechanisms. 
 
As noted above, A1R activation inhibits NHE3 by decreasing its intrinsic activity 
as well as surface protein. The mechanism whereby CHP binding to aa 462 to 552 
affects intrinsic transport NHE3 activity is unknown. It has recently been suggested that 
Ca2+ allows a conformational change of CHP and that conformational changes in CHP 
transduces cellular Ca2+ signals to other cellular proteins, somewhat akin to the role of 
calmodulin (66). Furthermore, CHP has potential phosphorylation sites for PKC (26). It 
is conceivable that a finite number of NHE3 proteins are bound to CHP under basal 
conditions. After CPA stimulation, the Ca2+-induced conformational change in CHP 
stimulates further association of CHP to NHE3 although Ca2+-dependent binding of 
CHP to NHE1 could not be demonstrated with recombinant proteins in vitro (28). PKC 
upon activation moves from the cytoplasm to plasmalemma. Since CHP1 associates 
with microtubules (30) and that the microtubule surface may provide a scaffold of two or 
more factors that otherwise do not directly interact (67), it is possible that the 
microtubule surface is responsible for bringing PKC into vicinity of NHE3. 
Phosphorylation of NHE-bound CHP may then inactivate NHE3 by directly altering the 
transport subdomain of NHE3. It has been proposed that CHP attenuates the 
stimulation of NHE1 by serum and a mutationally-activated GTPase in CCL39 cells by a 
change of CHP phosphorylation state (26,68). 
 
Comparable to previous findings in PS120 fibroblasts and OK cells expressing 
exogenous CHP2 (28,65), CHP partly co-localized with NHE3 in the surface membrane 
in OK cells and A6 cells. Microtubule dynamics appear to play a role in membrane 
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trafficking events (69), and EF-hand Ca2+-binding microtubule-interacting proteins, such 
as p22/CHP1 have been suggested to influence membrane trafficking by effecting either 
directly components of the vesicle transport machinery or indirectly the organization of 
the cytoskeleton (30). NHE3 is sensitive to the organization of the cytoskeleton (70). It is 
possible that CHP can exert its effect by altering the organization of the cytoskeleton. In 
the present study we also demonstrated that decreased surface expression of NHE3 
was associated with inhibition by prolonged exposure of A1R to CPA. CHP1 is involved 
in targeting/fusion of transcytotic vesicles with the apical membrane (25). Although, 
NHE3 is endocytosed into clathrin-coated vesicles (40,71), exactly how CHP regulates 
NHE3 trafficking is unclear. 
 
In summary, we present evidence for a novel function of the ubiquitous Ca+-
binding protein CHP. In epithelial cells of the kidney, we have shown that activation of 
A1R leads to increased interaction of NHE3 with CHP. Physical interaction of NHE3 with 
CHP is necessary for acute regulation of the intrinsic transport activity of NHE3. 
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Figure Legends 
 
Fig. 1: Effect of the A1R agonist CPA on native and transfected NHE activities in 
OK cells and A6 cells. NHE activity was assayed microfluorimetrically as rate of Na+-
dependent intracellular pH (pHi) recovery. CPA (10-6 M) was applied to the apical cell 
surface for 15 or 30 minutes as indicated. In OK cells stimulation of A1R was from the 
apical or basolateral site. In A6 cells where A1R are located in the apical membrane, 
CPA was added only to the apical cell surface. Data are expressed as percentage of 
activity of untreated cells. The number of experiments, each consisting of a pair of 
control and agonist treated cells, is given in parenthesis. Bars and error bars represent 
means and standard errors, respectively. Asterisks indicate statistical significance from 
control measurements (*P< 0.05; **P< 0.01, ANOVA). (A): Effect of CPA on apical NHE3 
activity in opossum kidney (OK) cells. (B): Effect of CPA on opossum NHE3 stably 
transfected into A6 cells. (C): Effect of CPA on rat NHE3 stably transfected into A6 cells. 
(D): Effect of CPA on endogenous basolateral Xenopus NHE (XNHE) in untransfected 
(A6/C1) and transfected A6 cell lines. 
 
Fig. 2: Effect of CPA on membrane NHE3 protein abundance in OK cells. CPA (10-6 
M for 15 or 30 min.) or vehicle-treated cells were labelled with biotin on cell surface and 
biotinylated proteins were precipitated with steptavidin-bound agarose. NHE3 
abundance was measured by immunoblot using anti-OK-NHE3 (#5683) antisera. Total 
cellular NHE3 protein abundance was measured on cell lysate by immunoblot. (A) 
Representative blot. (B) Summary of all experiments. Number of experiments is given in 
parenthesis and significance from control measurements is indicated by asterisks (*P< 
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0.05, ANOVA); (C) OK cells were transiently transfected with the NHE3/eGFP. Forty-
eight hours after transfection, cells were visualized by fluorescent microscopy prior to 
and after exposure to CPA or vehicle for 15 or 30 min.  
 
Fig. 3: Effect of CPA on apical membrane NHE3 protein abundance in A6 cells 
stably transfected with opossum NHE3. CPA (10-6 M for 15 or 30 min., apical 
addition) or vehicle-treated cells on permeable support were labelled with biotin on 
apical cell surface and biotinylated proteins were precipitated with steptavidin-bound 
agarose. NHE3 abundance was measured by immunoblot using anti-OK-NHE3 (#5683) 
antisera. Total cellular NHE3 protein abundance was measured on cell lysate by 
immunoblot. (A) Representative experiment. (B) Summary of results of effect of CPA on 
biotin-accessible NHE3 surface antigen; number of experiments is given in parenthesis 
and significance from control measurements is indicated by asterisks (*P< 0.05, 
ANOVA). (C) A6 cells were transiently transfected with the NHE3/eGFP construct. 
Forty-eight h after transfection, cells were visualized by fluorescent microscopy prior to 
and after exposure to CPA or vehicle for 15 or 30 min.  
 
Fig. 4: CPA- or PMA-induced modulation of the activity wild-type NHE3 and 
selected mutated forms of rat NHE3 stably transfected into A6 cells – Comparison 
to regulation of native basolateral Xenopus NHE (XNHE) activity. Na+/H+ exchange 
activity was measured microfluorimetrically as Na+-induced alkalinization (independent 
apical vs. basolateral Na+ addition) after an acid load (NH4Cl pulse/withdrawal). Pair-
wise comparisons of NHE activity were made before and after addition of either apical 
CPA (10-6 M for 15 min.) or PMA (10-7 M for 15 min.). The number of experiments 
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performed under identical experimental conditions is given in parenthesis. Bars and 
error bars represent means and standard errors, respectively. Asterisks indicate 
significant difference from control measurements (*P< 0.05; **P< 0.01, ANOVA). (A) 
Summary of effect of agonists on transfected NHE3 activities. (B) Summary of effect of 
agonists on native basolateral Xenopus NHE (XNHE) activity in untransfected (A6/C1) 
and transfected cell lines. Abbreviations: A6-ratNHE3, A6 cells stably transfected with 
wild-type rat NHE3; A6-ratNHE3S605G, A6 cells stably transfected with mutant NHE3 
(substitution of serine residue in position 605 by glycin); A6-ratNHE36Ser, A6 cells stably 
transfected with mutant NHE3 carrying a multitude of six point mutations (substitution of 
serine residues in position S513G, S552A, S575A, S661A, S690G, S804G by either 
glycin (G) or alanine (A) as indicated).  
 
Fig. 5: Effect of CPA or PMA on truncated versions of opossum NHE3 stably 
expressed in A6 cells. (A) Illustration of full length and truncation mutant forms of 
NHE3. The hydrophobic membrane-spanning terminus of NHE3 is shown as dark bar, 
while the portion of the hydrophilic C-terminus is shown as an open bar, with the amino 
acid position at the truncation site indicated for each mutant. (B) and (C). Effect of apical 
CPA (10-6 M, 15 min.) or PMA (10-7 M 15 min.) on NHE activity measured 
microfluorimetrically as rate of Na+-dependent intracellular pH (pHi) recovery. The 
number of experiments, each consisting of a pair of control and agonist treated cells, is 
given in parenthesis. Bars and error bars represent means and standard errors, 
respectively. Asterisks indicate significant difference from control measurements (*P< 
0.05; **P< 0.01, ANOVA). Abbreviations: NHE3∆mut, cells transfected with truncated 
versions of NHE3 as indicated in (A). (B) Summary of effect of agonists on transfected 
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NHE3 activities. (C) Summary of effect of agonists on native basolateral Xenopus NHE 
(XNHE) activity in untransfected (A6/C1) and transfected A6 cell lines. 
 
Figure 6: C-terminal murine NHE3 baits used in two-hybrid system screens. 
Various constructs derived form the C-terminus of murine NHE3 were used as baits 
against full length CHP as prey. Strength of interaction was determined semi-
quantitatively by ß-galactosidase assay and is indicated by “+” (+++, strong; ++, 
moderate; 0, no binding). 
 
Figure 7: Co-immunoprecipitation of CHP-NHE3 in OK cells. (A) Co-
immunoprecipitation of native NHE3 and CHP. Lysates obtained from OK cells were 
immunoprecipitated (IP) with either anti-CHP or anti-NHE3 antibodies and 
immunoblotted (IB) with anti-CHP antibody. OK cells were treated with either vehicle or 
CPA (10-6 M, 15 min.). (B) In the left panel, OK cells were transfected with HA-tagged 
CHP (HA/CHP) and 6His tagged NHE3 (His/NHE3). Untransfected cells served as 
negative controls. Arrows indicate expected mobilities of NHE3 and CHP. Right panel 
shows co-immunoprecipitation of His/NHE3 with HA/CHP in OK cells treated with either 
vehicle or CPA (10-6 M, 15 min.). (C): Co-immunoprecipitation of myc-tagged NHE3∆552 
(myc/NHE3∆552) with HA-tagged CHP (HA/CHP) in untransfected and transfected cells. 
Transfected cells were treated with either vehicle or CPA (10-6 M, 15 min.). (D): Left 
panel shows immunoprecipitation of myc-tagged NHE3∆462 (myc/NHE3∆462) and right 
panel shows co-immunoprecipitation of myc-tagged NHE3∆462 with HA-tagged CHP 
(HA/CHP) in untransfected and transfected cells. Transfected cells were treated with 
either vehicle or CPA as indicated above. Three independent experiments showed 
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similar results. (E): Summary of quantification of NHE3–CHP association. Ratios of the 
amount of co-immunoprecipitated CHP and NHE3 from CPA-treated (10-6 M for 15 
minutes) vs. vehicle-treated cells are presented. Bars and error bars represent means 
and standard errors, respectively. The numbers in parenthesis refer to the number of 
experiments performed under identical experimental conditions. Asterisk indicates the 
statistical difference compared with vehicle (*P< 0.05, ANOVA).  
 
Figure 8: Subcellular localization/colocalization of CHP and NHE3 in OK and A6 
cells. Constructs of HA/CHP and NHE3/eGFP (green) were transfected either alone or 
in combination into OK or A6 cells. Forty-eight hours after transfection, cells were fixed 
and immunostained with HA antibody (Rhodamine Red-X conjugated; red) and 
observed by confocal microscopy. Co-localization is indicated by the merged yellow 
color. XZ and XY indicate orthogonal optical sections. The apical membrane is specified 
by arrow on the XZ images. (A) subcellular distribution of CHP and NHE3 in OK or A6 
cells. (B) Co-localization of HA/CHP and NHE3/eGFP in OK cells. (C) Co-localization of 
HA/CHP and NHE3/eGFP in A6 cells. 
 
Figure 9: Overexpression of NHE3462-552 on CPA-mediated association of NHE3 
and CHP in OK cells. Left panel shows immunoprecipitation of Flag/NHE3462-552. The 
right panel shows co-immunoprecipitation of HA/CHP with His/NHE3 or Flag/NHE3462-
552 in OK cells triple transfected with the HA/CHP, His/NHE3 and Flag/NHE3462-552. For 
analysis of NHE3-CHP interaction cells were treated either with 10-6M CPA or vehicle 
for 15 minutes. 
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Figure 10: Localization of NHE3462-552 in OK cells: relative co-localization with 
NHE3 and CHP. OK cells were triple transfected with HA/CHP, NHE3/eGFP and 
Flag/NHE3462-552. Forty-eight hours after transfection, cells were fixed and 
immunostained with specific antibodies. To Flag/NHE3462-552 images a pseudo-color of 
either blue (A) or green (B, right) was assigned. Double-staining was performed using 
HA and Flag antibodies. XZ and XY indicate orthogonal optical sections. The apical 
membrane is specified by arrow on the XZ images. (A) Subcellular distribution of 
NHE3462-552. (B) Co-localization of CHP with NHE3 (right image) or NHE3462-552 (left 
image). 
 
Figure 11: Effect of NHE3462-552 on CPA-induced inhibition of NHE3 activity in OK 
cells. OK cells transfected with the pFlag vector or the pFlag/NHE3462-552 were tested 
for Na+/H+ exchange activity as Na+-dependent cell pH recovery after acid load. White 
bars represents the activity of NHE3 from vehicle treated cells and grey bars represent 
that of cells treated with 10-6 M CPA for 15 min. Bars and error bars represent means 
and standard errors, respectively. The numbers in parenthesis refer to the number of 
experiments performed under identical experimental conditions. Asterisk indicates the 
statistical difference compared with vehicle (*P< 0.05, ANOVA). 
 
Figure 12: Influence of knockdown of endogenous CHP on NHE3 total 
protein/activity and CPA-induced inhibition of NHE3 activity in OK cells. (A) Amino 
acid sequence alignment of the cloned opossum CHP with the C-terminus of murine, rat 
and human CHP1 sequence. (B) Representative immunoblot and quantification of CHP 
total protein content in untransfected and CHP, Pky2 or GL2 siRNA transfected OK 
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cells. 60 µg of total lysate was immunoblotted by anti-CHP antibody. Cells were 
exposed to transfection reagent either without siRNA (untransfected) or with siRNA 
against CHP (CHP siRNA), protein tyrosine kinase (Pyk2 siRNA) or non-mammalian 
protein (GL2 siRNA). Arrow indicates expected mobility of CHP. (C) Immunostaining of 
native CHP in untransfected (left image) and siRNA transfected OK cells (right image). 
Immunostaining was performed using anti-CHP antibody. XZ and XY indicate 
orthogonal optical sections. The apical membrane is indicated by arrow on the XZ 
image. (D) Typical immunoblot and quantification of native CHP, NHE3 and Na/K 
ATPasi total protein content in untransfected and CHP siRNA transfected OK cells. 60 
µg total lysate was immunoblotted by anti-CHP, anti-NHE3 (#5683) or anti-Na/K ATPasi 
(α2F) respectively. (E) NHE3 activity of untransfected or CHP siRNA transfected OK 
cells in response to a 15 minutes treatment with 10-6 M CPA or vehicle. Data presented 
are means ± S.E.M. The numbers in parenthesis refer to the number of experiments 
performed under identical experimental conditions. Asterisk indicates the statistical 
difference compared with untreated cells (*P< 0.05, **P< 0.01 ANOVA). 
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